Unravelling eribulin’s role in metastatic breast cancer: evaluating benefits for both triple negative and non-triple negative patients in real-world scenarios in resource-constrained settings
HIGHLIGHTS What: Since the patients were treated with standard institutional protocol and there was no direct contact between the researcher […]